By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
AVANIR Pharmaceuticals (AVNR) Making Strides With Alzheimer’s Drug, Says Analyst 11/24/2014 2:04:45 PM
AVANIR Pharmaceuticals (AVNR) To Participate In Two Conferences In December 11/20/2014 12:29:41 PM
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline 11/7/2014 8:31:20 AM
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Pivotal Phase 3 Results From AVP-825 Acute Migraine Study In The Journal "Headache" 10/31/2014 7:26:20 AM
AVANIR Pharmaceuticals (AVNR) Gives Suitors Two Big Reasons To Bid 10/31/2014 6:16:31 AM
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of AVP-923 Phase 2 Results In Agitation In Patients With Alzheimer's Disease At The American Neurological Association Meeting 10/13/2014 11:48:33 AM
AVANIR Pharmaceuticals (AVNR) To Host Investor Briefing On October 15, 2014 10/9/2014 9:21:36 AM
AVANIR Pharmaceuticals (AVNR) Announces Data Presentations At The American Neurological Association's (ANA) 2014 Annual Meeting Including Results From The Phase 2 Trial For Treatment Of Agitation In Patients With Alzheimer's Disease 10/8/2014 8:36:43 AM
AVANIR Pharmaceuticals (AVNR) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2014 10:08:58 AM
AVANIR Pharmaceuticals (AVNR) Announces Pricing Of Public Offering Of Common Stock 9/24/2014 8:16:32 AM